• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受癌症化疗的儿童使用的止吐药。

Antiemetics in children receiving cancer chemotherapy.

作者信息

Billett A L, Sallan S E

机构信息

Department of Pediatrics, Dana-Farber Cancer Institute, Boston, MA 02115.

出版信息

Support Care Cancer. 1994 Sep;2(5):279-85. doi: 10.1007/BF00365578.

DOI:10.1007/BF00365578
PMID:8000723
Abstract

Nausea and vomiting are debilitating side effects that often accompany the administration of chemotherapy and may lead to adverse physiological and psychological effects. Chemotherapy agents usually stimulate the chemoreceptor trigger zone, which then sends signals to the vomiting center in the medullary lateral reticular formation. The neurochemistry of vomiting involves serotonin and serotonin S3 receptors. Nausea and vomiting are difficult to treat once they have occurred, and prior poor antiemetic control may lead to future anticipatory nausea and vomiting. Thus, good antiemetic regimens must be prophylactic, scheduled, and individualized. Specific regimens must be adjusted to account for the emetogenic potential of the chemotherapy drug(s) being administered and the individual patient's preferences. The major classes of antiemetics include serotonin S3 receptor antagonists, phenothiazines and metoclopramide. Steroids are ineffective antiemetics alone but good potentiators of other antiemetics. We usually recommend a serotonin S3 receptor antagonist alone for less emetogenic regimens or in conjunction with dexamethasone for more emetogenic regimens. For breakthrough vomiting, we usually add lorazepam and/or scopolamine.

摘要

恶心和呕吐是化疗给药时常伴随出现的使人虚弱的副作用,可能会导致不良的生理和心理影响。化疗药物通常会刺激化学感受器触发区,该区域随后会向延髓外侧网状结构中的呕吐中枢发送信号。呕吐的神经化学涉及血清素和血清素S3受体。恶心和呕吐一旦发生就很难治疗,而且之前止吐控制不佳可能会导致未来出现预期性恶心和呕吐。因此,良好的止吐方案必须是预防性的、有计划的且个体化的。必须根据所使用化疗药物的致吐潜力和个体患者的偏好来调整具体方案。主要的止吐药类别包括血清素S3受体拮抗剂、吩噻嗪类和甲氧氯普胺。类固醇单独作为止吐药无效,但却是其他止吐药的良好增效剂。对于致吐性较低的方案,我们通常推荐单独使用血清素S3受体拮抗剂;对于致吐性较高的方案,则推荐与地塞米松联合使用。对于突发性呕吐,我们通常会加用劳拉西泮和/或东莨菪碱。

相似文献

1
Antiemetics in children receiving cancer chemotherapy.接受癌症化疗的儿童使用的止吐药。
Support Care Cancer. 1994 Sep;2(5):279-85. doi: 10.1007/BF00365578.
2
Advances in the management of nausea and vomiting induced by non-cisplatin containing chemotherapeutic regimens.不含顺铂化疗方案所致恶心呕吐的管理进展
Blood Rev. 1989 Dec;3(4):216-21. doi: 10.1016/0268-960x(89)90029-5.
3
Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.托烷司琼(呕必停)单药及与地塞米松联合用于预防化疗引起的呕吐:北欧的经验。
Semin Oncol. 1994 Oct;21(5 Suppl 9):20-6.
4
[Recent improvements in antiemetic therapy].[抗呕吐治疗的近期进展]
Tumori. 1997;83(2 Suppl):S3-14.
5
Chemotherapy-induced nausea and vomiting.化疗引起的恶心和呕吐。
Cancer J. 2008 Mar-Apr;14(2):85-93. doi: 10.1097/PPO.0b013e31816a0f07.
6
Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.托烷司琼(呕必停)单独或与其他止吐药联合使用预防化疗引起的恶心和呕吐。
Semin Oncol. 1994 Oct;21(5 Suppl 9):7-11.
7
Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood.用于预防和治疗儿童化疗引起的恶心和呕吐的止吐药物。
Cochrane Database Syst Rev. 2010 Sep 8(9):CD007786. doi: 10.1002/14651858.CD007786.pub2.
8
Prospective randomized comparison of tropisetron with and without dexamethasone against high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting.托烷司琼联合与不联合地塞米松对比大剂量甲氧氯普胺预防顺铂所致急性和迟发性恶心呕吐的前瞻性随机对照研究
Am J Clin Oncol. 1999 Apr;22(2):126-30. doi: 10.1097/00000421-199904000-00004.
9
Treatment of chemotherapy-induced emesis in the 1990s: impact of the 5-HT3 receptor antagonists.20世纪90年代化疗引起的呕吐的治疗:5-羟色胺3受体拮抗剂的影响。
Support Care Cancer. 1994 Sep;2(5):286-92. doi: 10.1007/BF00365579.
10
A retrospective review of antiemetic use for chemotherapy-induced nausea and vomiting in pediatric oncology patients at a tertiary care center.对一家三级护理中心儿科肿瘤患者化疗引起的恶心和呕吐的止吐药使用情况进行回顾性研究。
J Oncol Pharm Pract. 2013 Jun;19(2):138-44. doi: 10.1177/1078155212457966. Epub 2012 Oct 3.

引用本文的文献

1
Options for the prevention and management of acute chemotherapy-induced nausea and vomiting in children.儿童急性化疗引起的恶心和呕吐的预防与管理方案
Paediatr Drugs. 2003;5(9):597-613. doi: 10.2165/00148581-200305090-00003.
2
Antiemetic treatment for cancer chemotherapy: problems and progress.
Support Care Cancer. 1994 Sep;2(5):275-6. doi: 10.1007/BF00365576.

本文引用的文献

1
The prevention and treatment of motion sickness; seasickness.晕动病;晕船的预防与治疗。
Bull Johns Hopkins Hosp. 1949 May;84(5):470-90.
2
Dramamine.乘晕宁
Science. 1950 Mar 24;111(2882):312-3. doi: 10.1126/science.111.2882.312-c.
3
A new concept of organization of the central emetic mechanism: recent studies on the sites of action of apomorphine, copper sulfate and cardiac glycosides.中枢催吐机制组织的新概念:阿扑吗啡、硫酸铜和强心苷作用部位的近期研究
Gastroenterology. 1952 Sep;22(1):1-12.
4
Efficacy and safety of granisetron (Kytril) in two special patient populations: children and adults with impaired hepatic function.
Semin Oncol. 1994 Jun;21(3 Suppl 5):22-5.
5
Intravenous metoclopramide. An effective antiemetic in cancer chemotherapy.静脉注射胃复安。癌症化疗中一种有效的止吐药。
JAMA. 1982 May 21;247(19):2683-6. doi: 10.1001/jama.247.19.2683.
6
Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.大剂量甲氧氯普胺的止吐疗效:在化疗引起的恶心和呕吐患者中与安慰剂和丙氯拉嗪的随机试验
N Engl J Med. 1981 Oct 15;305(16):905-9. doi: 10.1056/NEJM198110153051601.
7
Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine.接受癌症化疗患者使用的止吐药:Δ⁹-四氢大麻酚与丙氯拉嗪的随机对照比较
N Engl J Med. 1980 Jan 17;302(3):135-8. doi: 10.1056/NEJM198001173020302.
8
The effectiveness of behavioral intervention for reduction of nausea and vomiting in children and adolescents receiving chemotherapy.行为干预对接受化疗的儿童和青少年减少恶心和呕吐的有效性。
J Clin Oncol. 1984 Jun;2(6):683-90. doi: 10.1200/JCO.1984.2.6.683.
9
Lorazepam: a randomized, double-blind, crossover study of a new antiemetic in patients receiving cytotoxic chemotherapy and prochlorperazine.
J Clin Oncol. 1984 Jun;2(6):691-5. doi: 10.1200/JCO.1984.2.6.691.
10
Antiemetic efficacy of dexamethasone therapy in patients receiving cancer chemotherapy.地塞米松治疗对接受癌症化疗患者的止吐疗效。
Arch Intern Med. 1983 Jul;143(7):1347-9.